SCHEMBL6977071

SCHEMBL6977071

COc1ccc2c(c1)c(OCc1ccccc1F)nn2S(=O)(=O)c1ccc(F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 13/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
TP53 P04637 1/20 0.43
GPR84 Q9NQS5 2/20 0.42
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
SLC6A4 P31645 1/20 0.41
HTR1A P08908 1/20 0.39
DRD2 P14416 1/20 0.39
HTR1D P28221 1/20 0.39
HTR1B P28222 1/20 0.39
HTR1E P28566 1/20 0.39
HTR1F P30939 1/20 0.39
HTR7 P34969 1/20 0.39
DRD3 P35462 1/20 0.39
PARP15 Q460N3 1/20 0.38
PARP10 Q53GL7 1/20 0.38
NPC1 O15118 1/20 0.38
NFKB1 P19838 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6965738 0.93 MAPT (0.44) HTR6TP53GPR84HTR1ADRD2
SCHEMBL6973700 0.87 HTR6 (0.45) HTR6CYP3A4CYP2D6TP53
SCHEMBL6977129 0.81 PPARG (0.43) HTR6CYP3A4CYP2D6
SCHEMBL6970750 0.80 MAPT (0.47) HTR6CYP3A4TP53SMN1; SMN2
SCHEMBL6966090 0.80 HTR6 (0.44) HTR6CYP3A4CYP2D6TP53
SCHEMBL6977499 0.79 MAPT (0.55) HTR6CYP3A4TP53SMN1; SMN2
SCHEMBL6967417 0.78 HTR6 (0.41) HTR6SMN1; SMN2
SCHEMBL6971073 0.78 ALDH1A1 (0.49) HTR6CYP3A4CYP2D6RAB9ASMN1; SMN2
SCHEMBL6977903 0.77 AR (0.46) HTR6TP53HTR2ADRD2HTR7
SCHEMBL6967275 0.77 HTR6 (0.42) HTR6CYP3A4CYP2D6TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077947-B1 NOVEL 1,5 AND 3-O-SUBSTITUTED 1H-INDAZOLES WITH ANTI-ASTHMATIC, ANTI-ALLERGIC, ANTI-INFLAMMATORY, IMMUNO-MODULATING AND NEURO-PROTECTIVE EFFECT, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS DRESDEN ARZNEIMITTEL (DE) 2003-09-03 EP claimed